Academics, Caregivers, Clinical Pharmacists, Clinical Pharmacologists, Clinicians, Educators, Family Practice Physicians, Formulary Managers, General Practitioners, Industrial Scientists, Internists, Nurse Practitioners, Nurse Practitioners/Physician Assistants, Nurses, Patients, Pharmaceutical Benefits Managers, Pharmacists, Pharmaco-Epidemiologists, Pharmacologists, Physician Assistants, Physicians, Physicians - Medicine, Policy Makers, Primary Care Physicians, Researchers, Residents, Rheumatologists
Rheumatology and Therapy is an international, open access, peer-reviewed, rapid publication journal. The journal is dedicated to the publication of high-quality clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of rheumatologic therapies. Studies relating to diagnosis, pharmacoeconomics, public health, quality of life, and patient care, management, and education are also encouraged. Areas of focus include, but are not limited to, rheumatoid arthritis, gout, gouty arthritis, psoriatic arthritis, osteoarthritis, juvenile idiopathic/rheumatoid arthritis, systemic lupus erythematosus, axial spondyloarthritis, Pompe’s disease, inflammatory joint conditions, musculoskeletal conditions, systemic sclerosis, and fibromyalgia. Rheumatology and Therapy provides an unrivalled rapid-publication journal for authors who want to disseminate their work to a worldwide audience as quickly as possible. Through its 'concierge service' from presubmission to online publication, the journal expedites publication of every article, keeping the authors informed every step of the way. The journal publishes all types of research whatever the outcome and will only reject papers based on major scientific or ethical flaws. The journal also publishes educational enhanced digital features.